BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 05:52 pm

Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....

Fermenta Biotech Ltd · 506414

✦ AI SummaryResults

Fermenta Biotech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.

Attachments (1)

📄

fa020e75-6fce-469a-82dc-c92f244c2ce1.pdf

pdf

Download →
View document text
August 4, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub: Notice of the Board Meeting Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 11, 2026, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter ended June 30, 2026. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019 and the Company’s intimation (to BSE Limited) regarding closure of trading window vide letter dated June 29, 2026, the “Trading Window" period (for trading in Company’s securities) has been closed with effect from July 1, 2026 and shall continue to remain closed till 48 hours after the declaration of unaudited financial results pursuant to the Board meeting to be held on August 11, 2026. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons and their immediate relatives and also Auditors and other Connected Persons shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their immediate relatives. Terms not defined in this notice shall have the same meaning as defined in the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders. This is for your information and record. Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861